Pseudomonas aeruginosa Liver Abscess as the First Manifestation of X-Linked Agammaglobulinemia With a Novel Mutation

J Investig Allergol Clin Immunol. 2017;27(2):129-131. doi: 10.18176/jiaci.0129.
No abstract available

Keywords: Children; Liver abscess; Primary immunodeficiencies; Pseudomonas aeruginosa; X-linked agammaglobulinemia.

Publication types

  • Case Reports

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Agammaglobulinemia / diagnosis
  • Agammaglobulinemia / drug therapy
  • Agammaglobulinemia / genetics*
  • Agammaglobulinemia / immunology
  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Candidiasis / drug therapy
  • Candidiasis / immunology
  • Candidiasis / microbiology
  • DNA Mutational Analysis
  • Genetic Diseases, X-Linked / diagnosis
  • Genetic Diseases, X-Linked / drug therapy
  • Genetic Diseases, X-Linked / genetics*
  • Genetic Diseases, X-Linked / immunology
  • Genetic Predisposition to Disease
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant
  • Liver Abscess, Pyogenic / diagnosis
  • Liver Abscess, Pyogenic / drug therapy
  • Liver Abscess, Pyogenic / immunology*
  • Liver Abscess, Pyogenic / microbiology
  • Male
  • Mutation*
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / immunology*
  • Opportunistic Infections / microbiology
  • Phenotype
  • Protein-Tyrosine Kinases / genetics*
  • Pseudomonas Infections / diagnosis
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / immunology*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / immunology*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Immunoglobulins, Intravenous
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase

Supplementary concepts

  • Bruton type agammaglobulinemia